Literature DB >> 1512421

Comparison of Nb2 lymphoma cell bioassay with immunoassay for human prolactin: the role of estrogen.

S Nader1, M D Warner, H G Friesen, C A Peabody.   

Abstract

The Nb2 lymphoma cell bioassay (BA-PRL) is a sensitive measure of serum prolactin under physiologic conditions. Since estrogens prime the lactotroph, prolactin heterogeneity and hence bioassayable prolactin may be influenced. A study was performed to observe the effect on BA-PRL of changing estradiol (E2) concentrations. In 13 normal subjects clomiphene citrate was administered to stimulate ovarian activity and blood samples were obtained before and after stimulation. Estradiol, BA-PRL and immunoassayable prolactin (RIA-PRL) were measured. While there was a substantial increase in E2 post-stimulation (p less than 0.001), there was no significant change in BA-PRL, RIA-PRL or BA/RIA-PRL ratios. Despite the lack of change in the mean BA/RIA-PRL ratio over a wide range of E2 concentrations that include and exceed those normally seen in spontaneous menstrual cycles, it is difficult to drawn conclusions regarding an association between E2 and BA/RIA-PRL ratios as there was no discernible change in the concentration of prolactin (possibly due to the antiestrogenic effect of clomiphene citrate).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512421     DOI: 10.1007/BF03348737

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

Review 1.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion.

Authors:  R I Weiner; W F Ganong
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

2.  Clinical value of prolactin bioassay in euprolactinemic reproductive disorders.

Authors:  K M Ataya; M G Subramanian; K S Moghissi; D M Magyar; M F Hayes; D M Lawson; R R Gala
Journal:  Fertil Steril       Date:  1988-01       Impact factor: 7.329

3.  Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.

Authors:  C R Smith; J Butler; I Hashim; M R Norman
Journal:  Ann Clin Biochem       Date:  1990-01       Impact factor: 2.057

4.  Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment.

Authors:  A Reinthaller; C Bieglmayer; J Deutinger; P Csaicsich
Journal:  Fertil Steril       Date:  1988-03       Impact factor: 7.329

5.  Clinical and laboratory predictors of clomiphene response.

Authors:  R A Lobo; M Gysler; C M March; U Goebelsmann; D R Mishell
Journal:  Fertil Steril       Date:  1982-02       Impact factor: 7.329

6.  Effect of clomiphene citrate on serum prolactin in infertile women with ovarian dysfunction.

Authors:  K Seki; M Seki; T Okumura; K Huang
Journal:  Am J Obstet Gynecol       Date:  1976-01-15       Impact factor: 8.661

7.  Quantitative comparison between biological and immunological activities of prolactin derived from human fetal and maternal sources.

Authors:  K Tomita; J A McCoshen; H G Friesen; J E Tyson
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

8.  Biological activity of serum prolactin in patients with primary hypothyroidism.

Authors:  C R Smith; J Butler; M R Norman
Journal:  Ann Clin Biochem       Date:  1988-09       Impact factor: 2.057

9.  A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

Authors:  T Tanaka; R P Shiu; P W Gout; C T Beer; R L Noble; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

10.  Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas.

Authors:  P W Gout; C T Beer; R L Noble
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.